Sponsor or institution

Clinical trials and research at Tempus AI

• 9Clinical trials
• 2Countries

Newest trials

All recruiting trials (9)

• Tempus Open Link registry for cancer patients using Olivia platform

  This registry tests whether Olivia can securely enroll cancer patients and combine their health data from EHRs and patient-reported outcomes to build a large, de-identified dataset.

  Recruiting Tempus AI · Chicago, Illinois · NCT07756034

• Using blood-based tumor DNA (ctDNA) to find leftover breast cancer after treatment

  This research will test whether a simple blood test that looks for tiny bits of tumor DNA can tell if people treated for breast cancer (including HR+/HER2-, HER2+, and triple-negative) still have leftover cancer or are at risk of recurrence.

  Recruiting at 16 sites Tempus AI · Birmingham, Alabama and 15 other locations · NCT07211178

• Longitudinal multi-center molecular biomarker registry for blood cancers

  This registry will collect serial blood samples and leftover tissue from people with AML or follicular lymphoma to see if molecular biomarkers predict disease course and treatment outcomes.

  Recruiting at 13 sites Tempus AI · Iowa City, Iowa and 12 other locations · NCT07154823

• AI-analyzed ECG to help find pulmonary hypertension in people with interstitial lung disease

  This project tests whether an AI-read 12-lead ECG can help doctors find hidden pulmonary hypertension in adults with interstitial lung disease.

  Recruiting at 41 sites Tempus AI · Birmingham, Alabama and 40 other locations · NCT06911632

• A biobank registry platform for cancer patients

  This study is testing how blood samples from cancer patients can help researchers learn more about tumor DNA and improve cancer treatments.

  Recruiting at 25 sites Tempus AI · Birmingham, Alabama and 31 other locations · NCT06207032

• Longitudinal biomarker profiling for patients with head and neck cancer

  This study is trying to see how the molecular makeup of head and neck cancer changes over time in patients who are receiving first-line anti-PD1 or PDL1 therapy.

  Recruiting at 31 sites Tempus AI · Duarte, California and 31 other locations · NCT06163534

• Observational study on small cell lung cancer patients receiving standard care

  This study looks at small cell lung cancer patients receiving their usual treatment to see how their tumor and blood samples can help us understand the disease better and improve future treatments.

  Recruiting at 7 sites Tempus AI · Los Alamitos, California and 10 other locations · NCT05257551

• Collecting health information from patients with non-small cell lung cancer

  This study is trying to collect health information from people with non-small cell lung cancer to see how their cancer changes over time and how it responds to treatment.

  Recruiting at 56 sites Tempus AI · Birmingham, Alabama and 57 other locations · NCT05236114

• Profiling blood biomarkers in colorectal cancer patients

  This study is testing how blood samples from colorectal cancer patients can help doctors understand how the disease is progressing and how well treatments are working.

  Recruiting at 20 sites Tempus AI · Fort Smith, Arkansas and 19 other locations · NCT05234177

Quick answers

How many clinical trials run by Tempus AI are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (9 trials), Puerto Rico (2 trials). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →